home | tags | mulvany.net


Adequate statistical power in clinical trials is associated with the combination of a male first author and a female last author.

So if your last author is female the quality of the science is statistically better. I don’t know exactly what to make of this. We also have to understand a bit about the role of last authorship. In life sciences this is usually the corresponding author. I would not be surprised (given the study looks over a 40 year period) that what we are seeing is that women just produce more carful better science, but are being restricted from first authorship positions because of bias. ... (more)

The Cost of Developers – by Ben Thompson

This is a fascinating post on what dynamics are in place between large companies and developers. The bottom line is that Microsoft has had to pay a large sum (>$7B) to acquire a developer friendly platform because they currently don’t really have one. In contrast Apple has a lot of leverage over developers on iOS, but not on other platforms. I’m not sure if there is a connection to researchers in the STM space, but some journals certainly have a lot of leverage over researchers. ... (more)

STM brainstorming session - 2013

Just attended the STM brainstroming session. I’ll update these notes in due course, and fix spelling issues, but I wanted to get the post live first. Notes I’ll just mention the things that I found interesting. ## Round1 Science Gists get a mention, yay!! Google scholar library gets a mention. Visualising data as maps is mentioned, mentions that there are no standards Howard mentions much richer tagging in the article, and upfront semantic tagging. ... (more)